| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |